Moderna Inc. presented new safety data from an early trial providing the first evidence that its Covid-19 vaccine stimulates the immune system of older people. In a Phase 1 trial, Moderna’s coronavirus vaccine produced “consistently high levels” of neutralizing antibodies – a key component of the body’s protective response – …
Read More »Modern Vaccine produces antibodies in trial of older people
